| Financial Year |
March 31 2023 |
| Monetary Funds |
177,024,849.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
338,667.29 |
| Accounts Receivable |
86,693,806.54 |
| Advances to Suppliers |
149,181,562.55 |
| Other Receivables |
22,496,492.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
233,377,578.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,451,948.51 |
| Total Current Assets |
676,564,905.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,451,447.42 |
| Investment Properties |
10,077,719.91 |
| Fixed Assetes |
928,491,678.41 |
| Under-construction Projects |
30,144,853.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
17,041,667.44 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
156,821,870.33 |
| R&D expenses |
-- |
| Goodwill |
225,901,330.74 |
| Long-Term Deferred and Prepaid Expenses |
78,681,234.22 |
| Deferred Income Tax Assets |
70,193,154.52 |
| Other Non-Current Assets |
52,702,510.83 |
| Sub-Total of Non-Current Assets |
2,002,892,769.39 |
| Total Assets |
2,679,457,674.72 |
| Short-Term Loans |
700,989,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
119,372,511.00 |
| Accounts Received In Advance |
31,572,784.50 |
| Employee Compensation Payable |
16,726,327.60 |
| Taxes Payable |
10,577,961.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
80,900,271.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
110,473,449.61 |
| Other Current Liabilities |
13,425,584.19 |
| Sub-Total of Current Liabilities |
1,189,962,104.34 |
| Long-term Loans |
237,805,142.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
14,365,300.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
31,222.65 |
| Deferred Income Tax Liabilities |
37,521,354.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
470,255,615.75 |
| Total Liabilities |
1,660,217,720.09 |
| Paid-In Capital(Or Share Stock) |
519,875,356.00 |
| Capital Surplus |
13,648,254.05 |
| Surplus Reserve |
215,812,810.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
87,394,335.72 |
| Minority Stockholder's Interest |
167,568,932.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
851,671,022.08 |
| Owner's Equity（Stockholder's Equity） |
1,019,239,954.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,679,457,674.72 |
